Home › Muscular Atrophy › NCT06631053
FIT Exercise in 30d of ULLS-induced Muscle Disuse
Use of Velocity Monitoring to Prescribe Appropriate Flywheel-based Inertial Training (FIT) Workloads for Exercise in Space Flight
Who can join
Ages 35 to 45 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Regularly engaging in aerobic exercise (\> 150min/wk) and resistance exercise (\>1 time per week) for the past 12 months * Education greater than or equal to bachelor's degree (any field) Exclusion Criteria: * Waist circumference \< 55cm or \> 90cm (F) and \< 75cm or \> 100cm (M) * Body mass index \< 18.5 or \> 29.9 * Shoe size \< 25 or \>29cm. * Not regularly engaging in exercise for previous 12 months * Tobacco use within previous 6 months * Blood clotting disorder * Heart arrhythmia * Implanted device which could negatively be affected by electrical impulse or strong magnetic field such as pacemaker, internal defibrillator, or cochlear implant * Diagnosed cardiovascular, pulmonary, renal, or metabolic disease * Pregnancy (within previous 6 months) * Oral contraceptive use (within previous three months) * High resting blood pressure (\>140 systolic and/or \> 90 diastolic) * Currently or previously undergone gender-affirming therapy (hormone therapy or sexual reassignment surgery) * Low back or leg injury in previous 6 months * Currently taking medication to assist with sleep * Muscle, bone, or joint injury that limits physical activity within previous 6 months * Neurological disorder which affects balance (such as multiple sclerosis or Parkinson's disease)
About the study
This study aims to determine how flywheel-based inertial training (FIT) implemented according to principles of velocity-based training (VBT) and High-Intensity Interval Training (HIIT) affects disuse-induced physical de-conditioning including loss of voluntary muscle strength, aerobic capacity, and balance regulation.
What is being tested
- velocity-based FIT (VBFIT) (other)
- No Exercise (other)
Sponsor: Lance Bollinger · Participants: 16 · Started: Oct 23, 2024
Contact the study team
- Lance Bollinger, PhD · Phone: 8592577904
Official record on ClinicalTrials.gov — NCT06631053
Locations in the U.S.
| Kentucky | University of Kentucky, Lexington |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.